Developers: | Boston Scientific |
Date of the premiere of the system: | July, 2019 |
Branches: | Pharmaceutics, medicine, health care |
2019: Announcement
At the end of July, 2019 the Boston Scientific company released a product which it called the long-lasting implant of a penis for treatment of erectile dysfunction providing natural feelings. New falloprotez is the first innovation in the field of penis implants from the producer for more than 10 years and represents evolution in development of flexible falloimplantat
Falloprotez under the name Tactra consists of two silicone layers which give it a natural view, and from a nitinolovy core for ensuring rigidity and durability. The simple implant in use rises manually for sexual intercourse and also easily cleans up after use. It can facilitate a status of many patients with erectile dysfunction who cannot take the oral drugs because of associated diseases.
The chief executive officer of Boston Scientific Michael Mahoney who made on July 24, 2019 the report on income provided falloprotez Tactra as an example of the new product developed in department of men's medicine. He also mentioned the problems with sterilization requiring the immediate solution - in connection with closing of the plant on sterilization with Sterigenics ethylene oxide in Uilloubruk, the State of Illinois, the company got into difficulties.
However the representative of Boston Scientific reported that regulatory bodies of the USA already provided to the company permission to sterilization of medical products for men on other sterilizing object included in a supply chain of the company.
Boston Scientific already put a product on the market of the USA and is going to begin its sales in Europe, Canada, Latin America, the Pacific Rim and Saudi Arabia at the end of 2019.[1]